195
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Doctor and patient awareness of treatment options for cervical intraepithelial neoplasia 1 (CIN 1): a survey questionnaire approach

, , , , , , , , & show all

References

  • Ang C, Mukhopadhyay A, Burnley C, Faulkner K, Cross P, Martin-Hirsch P, Naik R. 2011. Histological recurrence and depth of loop treatment of the cervix in women of reproductive age: incomplete excision versus adverse pregnancy outcome. BJOG: An International Journal of Obstetrics & Gynaecology 118:685–692.
  • Anon. 2015. Committee opinion No. 641: human papillomavirus vaccination. Obstetrics and Gynecology 126:e38–e43.
  • Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, et al. 2008. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 337:a1284.
  • Baldauf JJ, Ritter J. 1998. Comparison of the risks of cytologic surveillance of women with atypical cells or low-grade abnormalities on cervical smear: review of the literature. European Journal of Obstetrics, Gynecology, and Reproductive Biology 76:193–199.
  • Bansal N, Wright JD, Cohen CJ, Herzog TJ. 2008. Natural history of established low grade cervical intraepithelial (CIN 1) lesions. Anticancer Research 28:1763–1766.
  • Basen-Engquist K, Fouladi RT, Cantor SB, Shinn E, Sui D, Sharman M, Follen M. 2007. Patient assessment of tests to detect cervical cancer. International Journal of Technology Assessment in Health Care 23:240–247.
  • Boardman LA, Kennedy CM. 2008. Management of atypical squamous cells, low-grade squamous intraepithelial lesions, and cervical intraepithelial neoplasia 1. Obstetrics and Gynecology Clinics of North America 35:599–614.
  • Castel H, Bonneh DY, Sherf M, Liel Y. 2001. Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fractures. Osteoporosis International 12:559–564.
  • Castle PE, Rodriguez AC, Burk RD, Herrero R, Wacholder S, Hildesheim A, et al. 2011. Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer. The Journal of Infectious Diseases 203:814–822.
  • Ciavattini A, Clemente N, Tsiroglou D, Sopracordevole F, Serri M, Delli Carpini G, et al. 2017. Follow up in women with biopsy diagnosis of cervical low-grade squamous intraepithelial lesion (LSIL): how long should it be?. Archives of Gynecology and Obstetrics 295:997–1003.
  • Elit L, Levine MN, Julian JA, Sellors JW, Lytwyn A, Chong S, et al. 2011. Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia: a randomized trial in Canada and Brazil. Cancer 117:1438–1445.
  • Falls RK. 1999. Spontaneous resolution rate of grade 1 cervical intraepithelial neoplasia in a private practice population. American Journal of Obstetrics & Gynecology 181:278–282.
  • Gascon JJ, Sanchez-Ortuno M, Llor B, Skidmore D, Saturno PJ, Treatment Compliance in Hypertension Study Group. 2004. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Family Practice 21:125–130.
  • Geisler S, Speiser S, Speiser L, Heinze G, Rosenthal A, Speiser P. 2016. Short-term efficacy of trichloroacetic acid in the treatment of cervical intraepithelial neoplasia. Obstetrics & Gynecology 127:353–359.
  • Hamm RM, Loemker V, Reilly KL, Johnson G, Dubois P, Staveley-O'carroll K, et al. 1998. A clinical decision analysis of cryotherapy compared with expectant management for cervical dysplasia. The Journal of Family Practice 47:193–201.
  • Hartz LE, Fenaughty AM. 2001. Management choice and adherence to follow-up after colposcopy in women with cervical intraepithelial neoplasia 1. Obstetrics & Gynecology 98:674–679.
  • Huang AJ, Perez-Stable EJ, Kim SE, Wong ST, Kaplan CP, Walsh JM, et al. 2008. Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women. Journal of General Internal Medicine 23:1324.
  • Idestrom M, Milsom I, Andersson-Ellstrom A. 2003. Women's experience of coping with a positive Pap smear: a register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstetricia et Gynecologica Scandinavica 82:756–761.
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA: A Cancer Journal for Clinicians 61:69–90.
  • Jordan J, Martin-Hirsch P, Arbyn M, Schenck U, Baldauf JJ, Da Silva D, et al. 2009. European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology 20:5–16.
  • Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, Lee KH. 2015. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Research and Treatment 47:127–141.
  • Ki EY, Park JS. 2014. Natural history of human papillomavirus infection. Current Obstetrics and Gynecology Reports 3:123–127.
  • Lanneau GS, Skaggs V, Moore K, Stowell S, Zuna R, Gold MA. 2007. A LEEP cervical conization is rarely indicated for a two-step discrepancy. Journal of Lower Genital Tract Disease 11:134–137.
  • Lauver D, Rubin M. 1991. Women's concerns about abnormal Papanicolaou test results. Journal of Obstetric, Gynecologic & Neonatal Nursing 20:154–159.
  • Lee S, Kim JW, Hong JH, Song JY, Lee JK, Kim IS, Lee NW. 2014. Clinical significance of HPV DNA cotesting in Korean women with ASCUS or ASC-H. Diagnostic Cytopathology 42:1058–1062.
  • Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. 1991. Adverse psychologic consequences of positive cytologic cervical screening. American Journal of Obstetrics & Gynecology 165:658–662.
  • Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2013. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstetrics & Gynecology 121:829–846.
  • Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. 1998. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstetrics & Gynecology 92:727–735.
  • Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, et al. 2004. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 364:1678–1683.
  • Nam KH, Kwon JY, Kim YH, Park YW. 2010. Pregnancy outcome after cervical conization: risk factors for preterm delivery and the efficacy of prophylactic cerclage. Journal of Gynecologic Oncology 21:225–229.
  • Nasiell K, Roger V, Nasiell M. 1986. Behavior of mild cervical dysplasia during long-term follow-up. Obstetrics and Gynecology 67:665–669.
  • Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, et al. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354:20–25.
  • Ostor AG. 1993. Natural history of cervical intraepithelial neoplasia: a critical review. International Journal of Gynecological Pathology 12:186–192.
  • Peters T, Somerset M, Baxter K, Wilkinson C. 1999. Anxiety among women with mild dyskaryosis: a randomized trial of an educational intervention. The British Journal of General Practice: The Journal of the Royal College of General Practitioners 49:348–352.
  • Reelick NF, De Haes WF, Schuurman JH. 1984. Psychological side-effects of the mass screening on cervical cancer. Social Science & Medicine (1982) 18:1089–1093.
  • Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. 2012. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. American Journal of Clinical Pathology 137:516–542.
  • Vahedpoor Z, Jamilian M, Bahmani F, Aghadavod E, Karamali M, Kashanian M, Asemi Z. 2017. Effects of long-term Vitamin D supplementation on regression and metabolic status of cervical intraepithelial neoplasia: a randomized, double-blind, placebo-controlled trial. Hormones and Cancer 8:58–67.
  • Walker JL, Wang SS, Schiffman M, Solomon D, ASCUS LSIL Triage Study Group. 2006. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). American Journal of Obstetrics and Gynecology 195:341–348.
  • Waxman AG, Chelmow D, Darragh TM, Lawson H, Moscicki AB. 2012. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstetrics & Gynecology 120:1465–1471.
  • Wright TC, Jr., Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2007. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. American Journal of Obstetrics and Gynecology 197:340–345.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.